Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors
Timme, Natalie, Han, Youjia, Liu, Shuai, Yosief, Hailemichael O., García, Heathcliff Dorado, Bei, Yi, Klironomos, Filippos, MacArthur, Ian C., Szymansky, Annabell, von Stebut, Jennifer, Bardinet, Victor, Dohna, Constantin, Künkele, Annette, Rolff, Jana, Hundsdörfer, Patrick, Lissat, Andrej, Seifert, Georg, Eggert, Angelika, Schulte, Johannes H., Zhang, Wei, Henssen, Anton G.
Published in Translational oncology (01.02.2020)
Published in Translational oncology (01.02.2020)
Get full text
Journal Article
Abstract 2624: Dual PLK1 and BRD4 inhibition has synergistic therapeutic effects against high-risk rhabdomyosarcoma
Timme, Natalie, Liu, Shuai, Yosief, Hailemichael, García, Heathcliff Dorado, MacArthur, Ian, Szymansky, Annabell, Dohna, Constantin, Seifert, Georg, Hundsdörfer, Patrick, Lissat, Andrej, Eggert, Angelika, Schulte, Johannes, Zhang, Wei, Henssen, Anton
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article